260 related articles for article (PubMed ID: 27638348)
1. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Sardi JC; Gullo FP; Freires IA; Pitangui NS; Segalla MP; Fusco-Almeida AM; Rosalen PL; Regasini LO; Mendes-Giannini MJ
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):387-391. PubMed ID: 27638348
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Sun L; Liao K; Hang C
Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175
[TBL] [Abstract][Full Text] [Related]
3. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of the berberine and its synergism with fluconazole.
Iwazaki RS; Endo EH; Ueda-Nakamura T; Nakamura CV; Garcia LB; Filho BP
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
6. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of cinnamic acid and benzoic acid esters against Candida albicans strains.
Lima TC; Ferreira AR; Silva DF; Lima EO; de Sousa DP
Nat Prod Res; 2018 Mar; 32(5):572-575. PubMed ID: 28423912
[TBL] [Abstract][Full Text] [Related]
9. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
11. Activity of caffeic acid derivatives against Candida albicans biofilm.
De Vita D; Friggeri L; D'Auria FD; Pandolfi F; Piccoli F; Panella S; Palamara AT; Simonetti G; Scipione L; Di Santo R; Costi R; Tortorella S
Bioorg Med Chem Lett; 2014 Mar; 24(6):1502-5. PubMed ID: 24582984
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
13. Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.
Premachandra ID; Scott KA; Shen C; Wang F; Lane S; Liu H; Van Vranken DL
ChemMedChem; 2015 Oct; 10(10):1672-86. PubMed ID: 26263912
[TBL] [Abstract][Full Text] [Related]
14. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
[TBL] [Abstract][Full Text] [Related]
17. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
[TBL] [Abstract][Full Text] [Related]
18. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
Braga PC; Maci S; Dal Sasso M; Bohn M
Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
[TBL] [Abstract][Full Text] [Related]
19. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
20. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
Huang S; Cao YY; Dai BD; Sun XR; Zhu ZY; Cao YB; Wang Y; Gao PH; Jiang YY
Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
